Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
CoreWeave acquisition of Weights and Biases
We are advising CoreWeave on the transaction
NatWest Group £750 million contingent convertible additional Tier 1 notes
We advised NatWest Group on the SEC-registered offering
Recursion Pharmaceuticals $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
CCC Intelligent Solutions Holdings $433.7 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Rokt $404.2 million secondary transaction
We advised Rokt on the secondary transaction
Life Time $699 million secondary offering
The shares are listed on the New York Stock Exchange
Live Oak Acquisition V $230 million IPO
The units are listed on the Nasdaq Global Market
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
Rithm Acquisition $230 million SPAC IPO
We advised Rithm Acquisition Corp., a SPAC, on its IPO and NYSE listing
Mastercard $1.25 billion senior notes offering
We advised Mastercard on its investment-grade debt offering